Bioactive factors in platelet-rich plasma obtained by apheresis.
about
Strategies for controlled delivery of biologics for cartilage repair.The Chondrogenic Induction Potential for Bone Marrow-Derived Stem Cells between Autologous Platelet-Rich Plasma and Common Chondrogenic Induction Agents: A Preliminary Comparative StudyEffect of autologous platelet-rich plasma on the chondrogenic differentiation of rabbit adipose-derived stem cells in vitro.Knee osteoarthritis: hyaluronic acid, platelet-rich plasma or both in association?Cell and molecular biology of intervertebral disc degeneration: current understanding and implications for potential therapeutic strategies.Growth factors and platelet-rich plasma: promising biological strategies for early intervertebral disc degeneration.The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane.Advanced therapy medicinal products - a multiple challenge.Comparative Analysis of Different Platelet Lysates and Platelet Rich Preparations to Stimulate Tendon Cell Biology: An In Vitro Study.Initial boost release of transforming growth factor-β3 and chondrogenesis by freeze-dried bioactive polymer scaffolds.Platelet rich concentrate promotes early cellular proliferation and multiple lineage differentiation of human mesenchymal stromal cells in vitro.Platelet-Rich Plasma Increases Anti-inflammatory Markers in a Human Coculture Model for Osteoarthritis.Chemokine CCL25 Induces Migration and Extracellular Matrix Production of Anulus Fibrosus-Derived Cells
P2860
Q34791411-D3B080EC-A8D0-4755-A7AD-9C9DB7F1F3C2Q35230087-495D2931-582D-494C-B33F-C4265AF05D71Q35870380-F59DFD7E-5497-45C1-A8E0-4C9219C7F61EQ38188577-B12E2091-A1ED-4716-BEE3-5DFB0B0B067CQ38238933-7066ADF1-D79C-4411-A217-CEFA35D730A0Q38344714-41E6DD2E-B732-4C14-9ECF-4F1B6CA6323CQ38823159-74C03D61-5A62-4EC3-9D01-7076FDE17257Q41890519-0D8A0F6C-F51D-4301-B2DA-D3C0054E6BD8Q47740580-E33D7845-880D-435F-BC9A-BDC45AB91013Q52874228-F2BAB40A-1094-4542-9D88-AC4888760662Q53382309-94F34D39-83A5-4B0F-B5E6-43F9D384E36AQ53596712-607E12B0-48B8-430C-96F0-D51D7AADE5E6Q56964224-C3CED3B7-EE0C-43DD-9083-FBF71544B317
P2860
Bioactive factors in platelet-rich plasma obtained by apheresis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bioactive factors in platelet-rich plasma obtained by apheresis.
@en
Bioactive factors in platelet-rich plasma obtained by apheresis.
@nl
type
label
Bioactive factors in platelet-rich plasma obtained by apheresis.
@en
Bioactive factors in platelet-rich plasma obtained by apheresis.
@nl
prefLabel
Bioactive factors in platelet-rich plasma obtained by apheresis.
@en
Bioactive factors in platelet-rich plasma obtained by apheresis.
@nl
P2093
P2860
P356
P1476
Bioactive factors in platelet-rich plasma obtained by apheresis.
@en
P2093
Christian Kaps
Jan Philipp Krüger
Katja Neumann
Michaela Endres
Samuel Vetterlein
Undine Freymannx
P2860
P304
P356
10.1159/000356329
P577
2013-10-27T00:00:00Z